Rebecca Kondor
Overview
Explore the profile of Rebecca Kondor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rondy M, Azziz-Baumgartner E, Kondor R, Palekar R, Zhang W, Vicari A
J Infect Dis
. 2025 Feb;
231(Supplement_2):S87-S89.
PMID: 39891533
No abstract available.
2.
Chung J, Price A, Zimmerman R, Moehling Geffel K, House S, Curley T, et al.
Clin Infect Dis
. 2025 Jan;
PMID: 39761230
Background: The 2023-24 U.S. influenza season was characterized by a predominance of A(H1N1)pdm09 virus circulation with co-circulation of A(H3N2) and B/Victoria viruses. We estimated vaccine effectiveness (VE) in the United...
3.
Chung J, Price A, Zimmerman R, Moehling Geffel K, House S, Curley T, et al.
medRxiv
. 2024 Nov;
PMID: 39574872
Background: The 2023-24 U.S. influenza season was characterized by a predominance of A(H1N1)pdm09 virus circulation with co-circulation of A(H3N2) and B/Victoria viruses. We estimated vaccine effectiveness (VE) in the United...
4.
Perofsky A, Huddleston J, Hansen C, Barnes J, Rowe T, Xu X, et al.
Elife
. 2024 Sep;
13.
PMID: 39319780
Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals,...
5.
Forna A, Weedop K, Damodaran L, Hassell N, Kondor R, Bahl J, et al.
Proc Biol Sci
. 2024 Aug;
291(2028):20240790.
PMID: 39140324
The detection of evolutionary transitions in influenza A (H3N2) viruses' antigenicity is a major obstacle to effective vaccine design and development. In this study, we describe Novel Influenza Virus A...
6.
Chung J, Shirk P, Gaglani M, Mutnal M, Nowalk M, Moehling Geffel K, et al.
Influenza Other Respir Viruses
. 2024 Jun;
18(6):e13342.
PMID: 38923314
Background: The 2022-23 US influenza season peaked early in fall 2022. Methods: Late-season influenza vaccine effectiveness (VE) against outpatient, laboratory-confirmed influenza was calculated among participants of the US Influenza VE...
7.
Owuor D, de Laurent Z, Nyawanda B, Emukule G, Kondor R, Barnes J, et al.
Sci Rep
. 2023 Dec;
13(1):22342.
PMID: 38102198
Influenza viruses undergo rapid evolutionary changes, which requires continuous surveillance to monitor for genetic and potential antigenic changes in circulating viruses that can guide control and prevention decision making. We...
8.
Perofsky A, Huddleston J, Hansen C, Barnes J, Rowe T, Xu X, et al.
medRxiv
. 2023 Oct;
PMID: 37873362
Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals,...
9.
Ma K, Shirk P, Lambrou A, Hassell N, Zheng X, Payne A, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Jun;
72(24):651-656.
PMID: 37319011
CDC has used national genomic surveillance since December 2020 to monitor SARS-CoV-2 variants that have emerged throughout the COVID-19 pandemic, including the Omicron variant. This report summarizes U.S. trends in...
10.
Igboh L, Roguski K, Marcenac P, Emukule G, Charles M, Tempia S, et al.
Lancet Glob Health
. 2023 Apr;
11(5):e729-e739.
PMID: 37061311
Background: Using country-specific surveillance data to describe influenza epidemic activity could inform decisions on the timing of influenza vaccination. We analysed surveillance data from African countries to characterise the timing...